This week’s newsletter covers MDMA’s potential effects on memory, safety concerns around ibogaine, ethical questions in the psychedelic investment space, new research on CBD and liver health, prenatal cannabis exposure findings, cannabis for migraine relief, and CBD-rich therapy for children with autism.
Noteworthy Read
Recreational Ecstasy Use Is Linked to Lasting Memory Impairments (PsyPost)
Researchers found that frequent recreational MDMA use may be linked to lingering memory challenges. The findings highlight the difference between unsupervised party use and structured, therapeutic settings where dosing and safety are carefully managed.
Read more
View more in Psychedelics
More Noteworthy Reading
MAGA Marijuana: Raid on Secret NorCal Weapons Bunker (NY Post)
Authorities in Northern California uncovered a hidden underground bunker on a cannabis property that allegedly contained a large weapons stash. The story highlights how unregulated grow operations can sometimes intersect with broader political and criminal activity — a reminder of why transparent, accountable cannabis systems matter.
Read more
View more in THC
Learning From Ibogaine Fatalities (Ecstatic Integration)
This article reflects on documented ibogaine-related deaths and emphasizes the importance of heart screening, medical oversight, and responsible facilitation. For those exploring ibogaine for addiction healing, proper preparation and safety protocols are essential.
Read more
View more in Psychedelics
Psychedelic Venture Capitalist in the Epstein Files (Psychedelic State(s) of America)
An investigative piece explores connections between a well-known psychedelic investor and individuals linked to Jeffrey Epstein, raising ethical questions about power, money, and influence in the rapidly expanding psychedelic wellness space.
Read more
View more in Psychedelics
Research Round-Up
Study: No Association Between CBD and Liver Damage (LabRoots)
A new study found no meaningful link between typical CBD use and liver damage in healthy adults, offering reassurance for people using CBD for stress, sleep, or inflammation support. Researchers note that extremely high doses may still warrant monitoring, but everyday wellness use appears safe.
Read more
View more in CBD
In Utero Cannabis Exposure Not Associated With Later Developmental Delays (NORML)
A population analysis found no significant connection between prenatal cannabis exposure and later developmental delays in early childhood. While researchers continue to study long-term effects, the findings challenge some of the more alarming narratives around occasional prenatal exposure.
Read more
View more in Endocannabinoid System
Cannabis for Acute Migraine (UC San Diego Health)
New clinical research from UC San Diego suggests that inhaled cannabis can significantly reduce migraine pain and related symptoms when used during an attack. Participants reported meaningful relief, pointing to cannabis as a potential alternative for people who don’t respond well to conventional migraine medications.
Read more
View more in THC
CBD-Rich Cannabis Therapy for Children With Autism (Bentham Science)
A clinical review of CBD-rich cannabis treatments for children on the autism spectrum found improvements in anxiety, aggression, sleep, and social engagement in many cases. While dosing and long-term data still need refinement, the results support growing interest in cannabinoid-based support for neurodevelopmental conditions.
Read more
View more in CBD
A heartfelt thank you to all of the CBD brands whose generous support allows Project CBD to shine a light on the plant medicine research and stories that matter most to our community.
Be the first to comment